1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis. (29th March 2017) Authors: Renner, R.; Dissemond, J.; Goerge, T.; Hoff, N.; Kröger, K.; Erfurt‐Berge, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 11(2017) Page Start: 1884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The genetic basis for most patients with pustular skin disease remains elusive. (1st March 2018) Authors: Mössner, R.; Wilsmann‐Theis, D.; Oji, V.; Gkogkolou, P.; Löhr, S.; Schulz, P.; Körber, A.; Prinz, J.C.; Renner, R.; Schäkel, K.; Vogelsang, L.; Peters, K.‐P.; Philipp, S.; Reich, K.; Ständer, H.; Jacobi, A.; Weyergraf, A.; Kingo, K.; Kõks, S.; Gerdes, S. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The genetic basis for most patients with pustular skin disease remains elusive. (22nd January 2018) Authors: Mössner, R.; Wilsmann‐Theis, D.; Oji, V.; Gkogkolou, P.; Löhr, S.; Schulz, P.; Körber, A.; Prinz, J.C.; Renner, R.; Schäkel, K.; Vogelsang, L.; Peters, K.‐P.; Philipp, S.; Reich, K.; Ständer, H.; Jacobi, A.; Weyergraf, A.; Kingo, K.; Kõks, S.; Gerdes, S. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗